Related Experiment Videos
Pediatric considerations in tumor lysis syndrome
Lisa Truini-Pittman1, Carol Rossetto
1Memorial Sloan-Kettering Cancer Center, 1275 York Ave, M T835, New York, NY 10021, USA.
Seminars in Oncology Nursing
|August 20, 2002
Summary
Pediatric patients face high risks of tumor lysis syndrome (TLS) due to hematologic malignancies. Prompt monitoring and intervention are crucial for preventing life-threatening complications in children.
Area of Science:
- Pediatric Oncology
- Oncology Nursing
- Tumor Lysis Syndrome
Background:
- Pediatric patients have a high incidence of hematologic malignancies, increasing their risk for tumor lysis syndrome (TLS).
- TLS management in pediatric patients may differ from adults, necessitating specific monitoring and treatment protocols.
- Family and caregiver education are vital components of TLS management in pediatric oncology.
Purpose of the Study:
- To identify pediatric-specific issues in tumor lysis syndrome (TLS) monitoring and management.
- To compare pediatric TLS care with adult care.
- To outline essential family and caregiver education strategies for pediatric TLS.
Main Methods:
- Review of primary and tertiary literature.
- Incorporation of clinical experience.
Main Results:
- Pediatric patients are at significant risk for TLS, particularly those with hematologic malignancies.
- Immediate intervention for electrolyte and metabolic abnormalities is critical.
- Vigilant monitoring for risk factors and early identification are key to preventing severe TLS consequences.
Conclusions:
- Pediatric oncology nurses play a crucial role in managing TLS through monitoring and implementing prevention and treatment strategies.
- Proactive management, including preventive regimens and prompt correction of abnormalities, is essential for improving outcomes.
- Early detection and intervention are paramount in mitigating the life-threatening risks associated with TLS in pediatric patients.